— Know what they know.
Not Investment Advice

DERM NASDAQ

Journey Medical Corporation
1W: -2.2% 1M: +23.2% 3M: -26.9% YTD: -16.6% 1Y: -9.7% 3Y: +314.0%
$5.96
-0.25 (-4.03%)
 
Weekly Expected Move ±12.6%
$5 $6 $6 $7 $8
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Buy · Power 59 · $164.0M mcap · 15M float · 1.72% daily turnover · Short 37% of daily vol

Balance Sheet Trends

Total Assets
$95M +17.9% ▲
5Y CAGR: +12.8%
Total Liabilities
$63M +4.3% ▲
5Y CAGR: +8.6%
Shareholders Equity
$32M +58.7% ▲
5Y CAGR: +25.4%
Cash & Investments
$24M +18.6% ▲
5Y CAGR: +23.9%
Total Debt
$119K -99.5% ▼
5Y CAGR: -58.7%
Net Debt
-$24M -543.9% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$49M$32M$27M$20M$24M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$49M$32M$27M$20M$24M
Net Receivables$23M$28M$15M$10M$30M
Inventory$10M$14M$10M$14M$10M
Other Current Assets$2M$3M$4M$3M$3M
Total Current Assets$84M$78M$56M$48M$67M
Property, Plant & Equip.$89K$189K$101K$199K$111K
Goodwill & Intangibles$13M$27M$20M$32M$28M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$150K$95K$6K$0$0
Total Non-Current Assets$13M$27M$20M$32M$28M
Total Assets$97M$105M$77M$80M$95M
— Liabilities —
Accounts Payable$23M$37M$16M$16M$9M
Short-Term Debt$812K$3M$3M$625K$101K
Deferred Revenue$0$0$53K$0$0
Other Current Liabilities$25M$14M$4M$14M$28M
Total Current Liabilities$52M$67M$42M$35M$37M
Long-Term Debt$0$20M$15M$25M$18K
Other Non-Current Liab.$4M$1M$0$0$25M
Total Non-Current Liabilities$4M$21M$15M$25M$25M
Total Liabilities$55M$88M$56M$60M$63M
— Equity —
Common Stock$2K$2K$2K$2K$2K
Retained Earnings-$39M-$69M-$72M-$87M-$98M
Accumulated OCI-$0$0$0$0$0
Total Stockholders Equity$42M$17M$20M$20M$32M
Total Liabilities & Equity$97M$105M$77M$80M$95M
— Key Metrics —
Total Debt$910K$23M$18M$26M$119K
Net Debt-$48M-$9M-$10M$5M-$24M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms